On the other hand, different changes in the ALK gene—such as alternative splicing, amplification, and mutations—are linked to various tumors, such as inflammatory myofibroblastoma and NSCLC [4,5,6,7]. The gene discussed is ALK; the disease is non-small cell lung carcinoma.